Align Technology | ALGN - Operating Expenses


Align Technology reported $862.03M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
3M USD 3.26B 1.66B Mar/2026
Align Technology USD 862.03M 39.18M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Cardinal Health USD -2.83B 52M Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cooper Companies USD 811.3M 113.5M Dec/2025
CVS Health USD 95.75B 7.84B Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Henry Schein USD 3.17B 77M Mar/2026
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Masimo USD 326.2M 2.4M Mar/2026
McKesson USD 94.46B 10.04B Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Solventum Corp USD 4.97B 3.08B Mar/2026
Stryker USD 4.92B 284M Mar/2026
Teleflex USD 3.08B 2.55B Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Veeva Systems USD 609.84M 19.76M Mar/2026
Waters USD 1.12B 457.15M Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026
Zoetis USD 3.23B 1.68B Mar/2026